a-Pregnanediol is a metabolite of progesterone.
Progesterone is present in men but at a much lower level than found in premenopausal women. Progesterone is known as a female hormone, but males need progesterone to produce testosterone. Its function involves the development of sperm.
Pregnanediol is the major progesterone metabolite, and is present in appreciable quantities in the urine. Progesterone is not excreted in urine in detectable quantities. Thus, values of progesterone are very well “tracked” by pregnanediol values, and this value is an adequate reflection of free progesterone.
Alpha– and beta–Pregnanediol are usually used as surrogate markers, because they are the most abundant metabolites.
Natural production by the testes and adrenals in men starts to decrease with aging and can lead to an imbalance, not only of progesterone, but also lead to decreased testosterone and an increase of estrogen.
Metabolites of progesterone are measured in urine, including 5b-pregnanediol and 5a-pregnanediol. 5b-pregnanediol is inactive in the body but is the major metabolite of progesterone. 5a-pregnanediol is often a metabolite of more interest, as it can cross the blood brain barrier and up-regulate GABA activity and is considered neuroprotective to the brain. Both taken together represent the major metabolic end points for progesterone and can be used to represent total progesterone production.
Progesterone is produced by the corpus luteum following ovulation and to a lesser extent by the adrenal glands in both sexes. While found in the urine in small amounts, progesterone can be seen as a clinical marker of luteul activity and theraputic oral progesterone administration. The most important progesterone metabolite, pregnanediol (PDL), can serve as a urinary marker for endogenous progesterone levels and as an indicator of ovulation. PDL exists as two isomers, 5a-pregnanediol and 5b-pregnanediol. 5b-pregnanediol represents the majority end point of endogenous progesterone metabolism and appears to have little activity within the body, while 5α-pregnanediol, the lesser metabolite of PDL, can cross the blood brain barrier and may partially agonize GABA-A receptors. This action is possibly due to its role as an immediate precursor to allopregnanolone. Allopregnanolone is a potent neuroactive steroid capable of binding the GABA-A receptor often leading to sedative and anxiolytic action. The calming action of allopregnanolone is often seen with orally supplemented progesterone, as the liver metabolizes a large portion of oral progesterone to the neuroactive steroid allopregnanolone.
References:
-https://www.ncbi.nlm.nih.gov/pubmed/15669543
-http://digital.csic.es/bitstream/10261/166820/1/Prog.%20Neurobiol%202014.pdf
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.